The prevalence of type 2 diabetes in patients with autoimmune liver disease was 27.6%. Type 2 diabetes seems to reduce the risk of primary sclerosing cholangitis (PSC), and primary biliary cholangitis ...

Use of virtual reality significantly improves patient understanding of and confidence in the shock wave lithotripsy procedure.

All-cause mortality significantly lower with GLP-1 RA use, with consistent benefit across major cancer types, most GLP-1 RA types.

(HealthDay News) — Power outages may increase the risk for hospitalization among older U.S. adults, according to a study published online March 12 in PLOS Medicine.

Dyslipidemia should be treated earlier to reduce lifelong risk for prolonged exposure to atherogenic lipoproteins.

A spectrum of nondiabetic kidney diseases is associated with APOL1 high-risk genotypes (G1G1, G1G2, and G2G2), but the M1 variant has been understudied.

Findings from the FIND-CKD trial indicate finerenone may provide a new treatment option for slowing renal function loss in CKD patients without diabetes.

Antimitochondrial antibodies can be detected in patients with systemic lupus erythematosus (SLE) and appear prognostic.

Patients with connective tissue disease-associated PAH have 1-, 3-, and 5-year survival rates similar to those with idiopathic PAH.

The PAUSE-URO study evaluated the safety of a new protocol for patients using direct oral anticoagulants (DOACs) prior to elective urologic surgery.

(HealthDay News) — Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss appear to be similarly effective among adults across ages, races, and starting weights, according to a review ...

Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track designation is designed to ...